David V Smith - 05 Jun 2025 Form 4 Insider Report for IO Biotech, Inc. (IOBT)

Reporting relationship: Director
Issuer ticker: IOBT
Reported as of: 05 Jun 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 06 Jun 2025, 16:27:46 UTC
Prior SEC filing: 13 Jun 2024
Next SEC filing: 12 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Brian Burkavage, Attorney-in-Fact for David V. Smith

Key filing fact

David V Smith filed Form 4 for IO Biotech, Inc. (IOBT) on 06 Jun 2025.

Key facts

This page summarizes David V Smith's Form 4 filing for IO Biotech, Inc. (IOBT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 06 Jun 2025, 16:27.

Change

Previous filing in this sequence was filed on 13 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001229447 Primary reporting owner

Smith David V

Relationship: Director
Address: C/O IO BIOTECH, INC., OLE MAALOES VEJ 3, COPENHAGEN, DENMARK
Signature: /s/ Brian Burkavage, Attorney-in-Fact for David V. Smith
Signature date: 06 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IOBT transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +35,144
Change %
Price: $0.000000
Shares after: 35,144
Date: 05 Jun 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,144
Exercise price: $1.50
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These options vest on June 5, 2026, subject to the reporting person's continued service through the applicable vesting date, and subject to 100% acceleration upon a change of control.